MXPA02007688A - Metodo y composiciones para tratar una enfermedad antiinflamatoria. - Google Patents

Metodo y composiciones para tratar una enfermedad antiinflamatoria.

Info

Publication number
MXPA02007688A
MXPA02007688A MXPA02007688A MXPA02007688A MXPA02007688A MX PA02007688 A MXPA02007688 A MX PA02007688A MX PA02007688 A MXPA02007688 A MX PA02007688A MX PA02007688 A MXPA02007688 A MX PA02007688A MX PA02007688 A MXPA02007688 A MX PA02007688A
Authority
MX
Mexico
Prior art keywords
sodium
salicylate
ketoprofen
tolmetin
naproxen
Prior art date
Application number
MXPA02007688A
Other languages
English (en)
Spanish (es)
Inventor
Elizabeth T Keating
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MXPA02007688A publication Critical patent/MXPA02007688A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA02007688A 2000-02-08 2001-02-08 Metodo y composiciones para tratar una enfermedad antiinflamatoria. MXPA02007688A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18087900P 2000-02-08 2000-02-08
PCT/US2001/003972 WO2001058441A1 (en) 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease

Publications (1)

Publication Number Publication Date
MXPA02007688A true MXPA02007688A (es) 2002-12-13

Family

ID=22662062

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02007688A MXPA02007688A (es) 2000-02-08 2001-02-08 Metodo y composiciones para tratar una enfermedad antiinflamatoria.

Country Status (16)

Country Link
EP (1) EP1253919A4 (xx)
JP (1) JP2003522142A (xx)
KR (1) KR20020073577A (xx)
CN (1) CN1398181A (xx)
AU (1) AU7205701A (xx)
BR (1) BR0108087A (xx)
CA (1) CA2398184A1 (xx)
CZ (1) CZ20022682A3 (xx)
HK (1) HK1051319A1 (xx)
HU (1) HUP0300689A3 (xx)
IL (1) IL150963A0 (xx)
MX (1) MXPA02007688A (xx)
NO (1) NO20023737L (xx)
PL (1) PL356447A1 (xx)
WO (1) WO2001058441A1 (xx)
ZA (1) ZA200206252B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338971B2 (en) 2001-08-30 2008-03-04 El-Naggar Mawaheb M Treatment of inflammatory, cancer, and thrombosis disorders
CA2459757C (en) * 2001-09-19 2011-08-30 Altana Pharma Ag Combination
MXPA04003668A (es) * 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
WO2004098605A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
WO2005020926A2 (en) * 2003-08-28 2005-03-10 Pharmacia Corporation Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors
EP2400961B1 (de) * 2009-02-27 2017-11-22 Boehringer Ingelheim International GmbH Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids
EP2400962B1 (de) * 2009-02-27 2017-11-08 Boehringer Ingelheim International GmbH Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids
SG186989A1 (en) 2010-07-14 2013-02-28 Novartis Ag Ip receptor agonist heterocyclic compounds
TW201335160A (zh) 2012-01-13 2013-09-01 Novartis Ag Ｉｐ受體激動劑之雜環化合物
JP2016507582A (ja) 2013-02-13 2016-03-10 ノバルティス アーゲー Ｉｐ受容体アゴニスト複素環式化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061779A (en) * 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
AU677776B2 (en) * 1992-04-02 1997-05-08 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
FR2753706B1 (fr) * 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
ZA200206252B (en) 2003-08-26
BR0108087A (pt) 2002-10-29
HK1051319A1 (zh) 2003-08-01
WO2001058441A1 (en) 2001-08-16
JP2003522142A (ja) 2003-07-22
KR20020073577A (ko) 2002-09-27
HUP0300689A3 (en) 2003-09-29
NO20023737L (no) 2002-09-27
CA2398184A1 (en) 2001-08-16
EP1253919A1 (en) 2002-11-06
AU7205701A (en) 2001-08-20
IL150963A0 (en) 2003-02-12
CZ20022682A3 (cs) 2003-09-17
EP1253919A4 (en) 2007-03-14
CN1398181A (zh) 2003-02-19
NO20023737D0 (no) 2002-08-07
HUP0300689A2 (hu) 2003-07-28
PL356447A1 (en) 2004-06-28

Similar Documents

Publication Publication Date Title
US20010056122A1 (en) Therapies for treating pulmonary diseases
JP2004538302A (ja) 新規治療方法
MXPA02007688A (es) Metodo y composiciones para tratar una enfermedad antiinflamatoria.
PL210463B1 (pl) Zastosowanie kombinacji roflumilastu z diklofenakiem w leczeniu zapalnych chorób stawów
US20040176419A1 (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases
NZ506020A (en) Use of pharmaceutical combinations containing tramadol and an antiemetic
KR20020086749A (ko) 베타 블록커 및 콜레스테롤 저하제의 신규한 조합물
US20040171593A1 (en) Method and compositions for treating an inflammatory disease
CN101193656B (zh) 甘油三酸酯降低剂
TWI242431B (en) Pharmaceutical compositions for treating pulmonary diseases
CA2417336A1 (en) Method for reducing exacerbations associated with copd
WO2001060358A1 (en) Method and compositions for treating fibrotic diseases
US20030018071A1 (en) Method and compositions for treating fibrotic diseases
AU2004240185A1 (en) Method and compositions for treating an inflammatory disease
NO317593B1 (no) Fremgangsmate til a behandle pulmonal hypertensjon
US20040214805A1 (en) Method and compositions for treating pulmonary diseases
MXPA06002049A (es) Una composicion farmaceutica para el tratamiento de la obesidad o para facilitar o promover la perdida de peso.
AU2002310620A1 (en) Composition comprising a PDE-4 inhibitor and H1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment respiratory diseases
MXPA01001994A (en) Therapies for treating pulmonary diseases
ZA200502225B (en) Combination of atorvastatin and alpha1, adrenergicreceptor antagonists.
AU2004205324A1 (en) Method and compositions for treating pulmonary diseases
Letsoalo Development and evaluation of a combination analgesic capsule

Legal Events

Date Code Title Description
FA Abandonment or withdrawal